SYRE
Spyre Therapeutics Inc.
$73.65
-$0.40(-0.54%)
49
Overall
60
Value
66
Tech
21
Quality
Market Cap
$1.65B
Volume
478.43K
52W Range
$13.93 - $76.00
Target Price
$95.20
EPS Estimates Overview
| Current Quarter | $-0.7 | Next Quarter | $-0.7 |
| Current Year | $-2.79 | Next Year | $-3.12 |
| QoQ Growth | +0.0% | YoY Growth | -11.8% |
| 3Y EPS CAGR | +56.9% | Target Price | $95.20 |
| Consensus | Buy | Upside | +29.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $73.65 | -0.5% | 478.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |